Ethnic groups and high sensitivity C-reactive protein in Israel

Biomarkers

Volumn 13, Issue 3, 2008, Pages 296-306

  Wolach, Ofir ^a,b   Arbel, Yaron ^b,c   Cohen, Michael ^c   Goldbourt, Uri ^b   Rebhun, Uzi ^d   Shapira, Itzhak ^c   Berliner, Shlomo ^c   Rogowski, Ori ^c  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Ethnicity; Gender; High sensitivity C reactive protein; Jewish

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL CONTRACEPTIVE AGENT; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ETHNIC DIFFERENCE; ETHNICITY; EXERCISE; FEMALE; HORMONE SUBSTITUTION; HUMAN; ISRAEL; JEW; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK ASSESSMENT; SEX DIFFERENCE; THROMBOSIS; WAIST CIRCUMFERENCE;

ADULT; ARTERIES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; ETHNIC GROUPS; FEMALE; HUMANS; ISRAEL; JEWS; MALE; MIDDLE AGED; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THROMBOSIS;

EID: 42449156340     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500701800023     Document Type: Article

References (36)

1. Albert, MA, Glynn, RJ, Buring, J. and Ridker, PM. (2004) C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). American Journal of Cardiology, 93, pp. 1238-1242.
2. Anand, SS, Razak, F., Yi, Q., Davis, B., Jacobs, R., Vuksan, V., Lonn, E., Teo, K., McQueen, M. and Yusuf, S. (2004) C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arteriosclerosis, Thrombosis. and Vascular Biology, 24, pp. 1509-1515.
3. Berliner, S., Shapira, I., Toker, S., Melamed, S., Shirom, A. and Rogowski, O. (2005) Benign hereditary leukopenia-neutropenia does not result from lack of low grade inflammation. A new look in the era of microinflammation. Blood. Cells Molecules & Disease, 34, pp. 135-140.
4. Best, LG, Zhang, Y., Lee, ET, Yeh, JL, Cowan, L., Palmieri, V., Roman, M., Devereux, RB, Fabsitz, RR, Tracy, RP, Robbins, D., Davidson, M., Ahmed, A. and Howard, BV. (2005) C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study. Circulation, 112, pp. 1289-1295.
5. Central Bureau of Statistics (2005) Population by population group, religion, age and sex, district and sub-district. Statistical abstract of Israel 2005. Central Bureau of Statistics, Jerusalem
6. Chambers, JC, Eda, S., Bassett, P., Karim, Y., Thompson, SG, Gallimore, JR, Pepys, MB and Kooner, JS. (2001) C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation, 104, pp. 145-150.
7. Crawford, DC, Sanders, CL, Qin, X., Smith, JD, Shephard, C., Wong, M., Witrak, L., Rieder, MJ and Nickerson, DA. (2006) Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation, 114, pp. 2458-2465.
8. DellaPergola, S. and Even, J. (2001) Papers in Jewish Demography 1997, The Hebrew University of Jerusalem, Jerusalem
9. Friedlander, Y., Kark, JD, Sinnreich, R., Tracy, RP and Siscovick, DS. (2006) Fibrinogen and CRP in Israeli families: Genetic and environmental sources of concentrations and longitudinal changes. Atherosclerosis, 189, pp. 169-177.
10. Frohlich, M., Imhof, A., Berg, G., Hutchinson, WL, Pepys, MB, Boeing, H., Muche, R., Brenner, H. and Koenig, W. (2000) Association between C-reactive protein and features of the metabolic syndrome: A population-based study. Diabetes Care, 23, pp. 1835-1839.
11. Imhof, A., Froehlich, M., Brenner, H., Boeing, H., Pepys, MB and Koenig, W. (2001) Effect of alcohol consumption on systemic markers of inflammation. Lancet, 357, pp. 763-767.
12. Kerner, A., Avizohar, O., Sella, R., Bartha, P., Zinder, O., Markiewicz, W., Levy, Y., Brook, GJ and Aronson, D. (2005) Association between elevated liver enzymes and C-reactive protein: Possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, pp. 193-197.
13. Khera, A., de Lemos, JA, Peshock, RM, Lo, HS, Stanek, HG, Murphy, SA, Wians Jr, FH, Grundy, SM and McGuire, DK. (2006) Relationship between C-reactive protein and subclinical atherosclerosis: The Dallas Heart Study. Circulation, 113, pp. 38-43.
14. Kuller, LH, Arnold, AM, Psaty, BM, Robbins, JA, O'Leary, DH, Tracy, RP, Burke, GL, Manolio, TA and Chaves, PH. (2006) 10-year follow-up of subclinical cardiovascular disease and risk of coronary heart disease in the Cardiovascular Health Study. Archives of Internal Medicine, 166, pp. 71-78.
15. Kushner, I., Rzewnicki, D. and Samols, D. (2006) What does minor elevation of C-reactive protein signify?. American Journal of Medicine, 119116, pp. e17-e28.
16. Laaksonen, DE, Niskanen, L., Nyyssonen, K., Punnonen, K., Tuomainen, TP and Salonen, JT. (2005) C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men: A population-based cohort study. European Heart Journal, 26, pp. 1783-1789.
17. Larbi, A., Dupuis, G., Douziech, N., Khalil, A. and Fulop Jr, T. (2004) Low-grade inflammation with aging has consequences for T-lymphocyte signaling. Annals of New York Academy of Sciences, 1030, pp. 125-133.
18. Libby, P., Ridker, PM and Maseri, A. (2002) Inflammation and atherosclerosis. Circulation, 105, pp. 1135-1143.
19. National Cholesterol Education Program (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 285, pp. 2486-2497.
20. Paffen, E. and DeMaat, MP. (2006) C-reactive protein in atherosclerosis: A causal factor?. Cardiovascular Research, 71, pp. 30-39.
21. Pankow, JS, Folsom, AR, Cushman, M., Borecki, IB, Hopkins, PN, Eckfeldt, JH and Tracy, RP. (2001) Familial and genetic determinants of systemic markers of inflammation: The NHLBI family heart study. Atherosclerosis, 154, pp. 681-689.
22. Petersen, AM and Pedersen, BK. (2005) The anti-inflammatory effect of exercise. Journal of Applied Physiology, 98, pp. 1154-1162.
23. Pirro, M., Schillaci, G., Savarese, G., Gemelli, F., Vaudo, G., Siepi, D., Bagaglia, F. and Mannarino, E. (2004) Low-grade systemic inflammation impairs arterial stiffness in newly diagnosed hypercholesterolaemia. European Journal of Clinical Investigation, 34, pp. 335-341.
24. Rexrode, KM, Pradhan, A., Manson, JE, Buring, JE and Ridker, PM. (2003) Relationship of total and abdominal adiposity with CRP and IL-6 in women. Annals of Epidemiology, 13, pp. 674-682.
25. Ridker, PM, Buring, JE, Cook, NR and Rifai, N. (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women. Circulation, 107, pp. 391-397.
26. Ridker, PM, Cannon, CP, Morrow, D., Rifai, N., Rose, LM, McCabe, CH, Pfeffer, MA and Braunwald, E. (2005) C-reactive protein levels and outcomes after statin therapy. New England Journal of Medicine, 352, pp. 20-28.
27. Ridker, PM, Hennekens, CH, Rifai, N., Buring, JE and Manson, JE. (1999) Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation, 100, pp. 713-716.
28. Ridker, PM, Rifai, N., Rose, L., Buring, JE and Cook, NR. (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England Journal of Medicine, 347, pp. 1557-1565.
29. Rifai, N., Tracy, RP and Ridker, PM. (1999) Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clinical Chemistry, 45, pp. 2136-2141.
30. Rogowski, O., Toker, S., Shapira, I., Melamed, S., Shirom, A., Zeltser, D. and Berliner, S. (2005) Values of high-sensitivity C-reactive protein in each month of the year in apparently healthy individuals. American Journal of Cardiology, 95, pp. 152-155.
31. Rogowski, O., Zeltser, D., Shapira, I., Burke, M., Zakut, V., Mardi, T., Ben-Assayag, E., Serov, J., Rozenblat, M. and Berliner, S. (2004) Gender difference in C-reactive protein concentrations in individuals with atherothrombotic risk factors and apparently healthy ones. Biomarkers, 9, pp. 85-92.
32. Santos, AC, Lopes, C., Guimaraes, JT and Barros, H. (2005) Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome. International Journal of Obesity (Lond), 29, pp. 1452-1456.
33. Tsioufis, C., Dimitriadis, K., Taxiarchou, E., Vasiliadou, C., Chartzoulakis, G., Tousoulis, D., Manolis, A., Stefanadis, C. and Kallikazaros, I. (2006) Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects. American Journal of Hypertension, 19, pp. 462-466.
34. Warnberg, J., Nova, E., Moreno, LA, Romeo, J., Mesana, MI, Ruiz, JR, Ortega, FB, Sjostrom, M., Bueno, M. and Marcos, A. (2006) Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: The AVENA Study. American Journal of Clinical Nutrition, 84, pp. 505-512.
35. Yasue, H., Hirai, N., Mizuno, Y., Harada, E., Itoh, T., Yoshimura, M., Kugiyama, K. and Ogawa, H. (2006) Low-grade inflammation, thrombogenicity, and atherogenic lipid profile in cigarette smokers. Circulation Journal, 70, pp. 8-13.
36. Zeltser, D., Rogowski, O., Berliner, S., Mardi, T., Justo, D., Serov, J., Rozenblat, M., Avitzour, D. and Shapira, I. (2004) Sex differences in the expression of haemorheological determinants in individuals with atherothrombotic risk factors and in apparently healthy people. Heart, 90, pp. 277-281.